Ontology highlight
ABSTRACT:
SUBMITTER: Winer AG
PROVIDER: S-EPMC4864362 | biostudies-literature | 2016 Feb
REPOSITORIES: biostudies-literature
Winer Andrew G AG Motzer Robert J RJ Hakimi A Ari AA
The Urologic clinics of North America 20151031 1
Improved understanding of renal carcinoma disease biology has led to the discovery and approval of five novel therapies targeting specific molecules in the vascular endothelial growth factor (VEGF) biochemical pathway. Biomarker studies attempting to predict response to VEGF-targeted therapies have largely focused on circulating proteins, tissue-based molecules, and germline polymorphisms. Thus far studies have yielded conflicting results that require prospective validation; therefore no definit ...[more]